1. | captureME | |
2. | GarryPierce | |
3. | greatLegends45 | |
4. | AbeBuy | |
5. | thenutbreaker |
1. | captureME | |
2. | GarryPierce | |
3. | greatLegends45 | |
4. | AbeBuy | |
5. | thenutbreaker |
1. | greatLegends45 09/29/2017 They are in the works of sharing full data |
2. | AbeBuy 03/05/2018 Zynerba Pharmaceuticals Announces Positive Meeting with U.S. Food and Drug Administration and Plans to Conduct a Single Pivotal Study of ZYN002 in Fragile X Syndrome to Support an NDA Filing |
3. | captureME 01/29/2018 Amazing price action |
4. | thenutbreaker 09/28/2017 Closing that gap |
5. | captureME 01/29/2018 I’ll bet they head to $20 by end of half |
6. | PortfolioPaulie87 09/28/2017 Went up 50% overnight |
7. | captureME 09/28/2017 HERE IS THE LINK: {Link} |
8. | captureME 04/25/2018 Zynerba Pharmaceuticals Announces Twelve Month ZYN002 Data from STAR 2 Study in Patients with Focal Seizures at the 2018 Annual Meeting of the American Academy of Neurology (AAN) |
9. | wilgordo 02/01/2018 H.C. Wainwright & Co.resumes as a buy, |
10. | AbeBuy 03/26/2018 Zynerba Pharmaceuticals Announces Publication of Preclinical Data in Neuropsychopharmacology Demonstrating Effect of Cannabidiol Gel Treatment in Reduction of Relapse in an Addiction Model |